Within the Horizon 2020 framework program the EU has rewarded the ‘MyLeg’ project with a total budget of 4.5M Euro. The MyLeg project is a collaborative project between the University of Groningen (NL) as coordinator, the University of Bologna (IT), the University of Twente (NL), Roessingh Research and Development (NL), Radboud university medical centre Nijmegen (NL), Össur (IS) and Norwest Advanced Orthopaedics (AUS).The goal of the project is to develop a new generation osseo-integrated amputation prostheses. The MyLeg prosthetic system will enhance the human-prosthesis interaction, perception, and motion capabilities; it will include implantable myoelectric sensors on targeted reinnervated muscles to realize an intuitive EMG control and to provide a high-level of cognition abilities; it will implement variable stiffness actuators realized with stress-stiffening nanostructured materials that guarantee high adaptability with respect to different tasks, dependability, and decisional autonomy; it will exploit light-weighted nanofibrous materials for sensing and energy harvesting. These new techniques will be implemented in prosthetic prototypes after which the efficiency of these devices will be demonstrated in patients at the Radboudumc.
Involved Radboudumc researchers are Jan-Paul Frölke (General Surgery), Henk van der Meent (Rehabilitation Medicine) and Nico Verdonschot (Orthopaedics), within the themes Reconstructive and regenerative medicine and Disorders of movement.
Related news items
Radboudumc Master Prize for Mark van Goor18 June 2019
Mark van Goor, theme Renal disorders, received the Radboudumc Master Prize for his MSc thesis entitled “High-resolution structure of the renal calcium channel TRPV5 revealed with cryo-EM”, which was based on his internship at the lab of Prof. Yifan Cheng, USA.read more
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies18 June 2019
Exome sequencing may provide a genetic diagnosis in a significant number of patients in a single genetic test. Alexander Hoischen and Mihai Netea, theme Infectious diseases and global health, and colleagues, published their results in Genome Medicine.read more
Lowering cholesterol is not enough to reduce hyperactivity of the immune system14 June 2019
In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.read more